<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02898636</url>
  </required_header>
  <id_info>
    <org_study_id>9552</org_study_id>
    <nct_id>NCT02898636</nct_id>
  </id_info>
  <brief_title>Identification of Biomarkers in the Legal Medical Skin Wounds</brief_title>
  <official_title>Identification of Protein Markers of Vitality in Skin Wounds by Forensic Multiplex Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Identify the cytokine or combination of cytokines, with the best diagnostic performance to
      characterize the vital nature of a skin wound in the body.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Determining the vitality of skin wounds, that is to say their antemortem character, is an
      important issue in forensic pathology. The only criterion vitality currently recognized (but
      whose diagnostic performance remains limited) is the microscopic demonstration of an
      inflammatory infiltrate of neutrophils. The search for more reliable diagnostic biomarkers is
      required. By their early expression of the injury site, inflammatory cytokines are potential
      candidates and their quantification in injured skin could optimize the diagnosis of vitality
      injury.

      The objective is to identify the cytokine or combination of cytokines, with the best
      diagnostic performance to characterize the vital nature of a skin wound in the body.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2016</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>measures cytokines</measure>
    <time_frame>1 day</time_frame>
    <description>multiplex analysis electrochemoluminescence: Six cytokines candidates selected from a literature review (IFN-γ, IL-1β, IL-6, IL-10, IL-12 p70, TNF-α) will be assayed in conjunction with the MSD technology (V-PLEX proinflammatory Panel 1 human Kit) after tissue extraction and determination of total protein concentration in each sample.</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Legal Medical Skin Wounds</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>autopsy</intervention_name>
    <description>At autopsy achieving adequate sampling of lesions and healthy skin</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient undergoing a forensic autopsy
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult died 18 years or more

          -  Having at least one recent ante-mortem skin wound (occurring less than 4 hours prior
             to death)

          -  Hours of death and the establishment of the ante-mortem wound known (date, hours and
             minutes)

        Exclusion Criteria:

          -  Immunocompromised patients (HIV infection, immunosuppressive therapy ...)

          -  Putrefaction signs (abdominal patch of green ...)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre-Antoine PEYRON, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pierre-Antoine PEYRON, MD</last_name>
    <phone>467338586</phone>
    <phone_ext>33</phone_ext>
    <email>pa-peyron@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>PEYRON</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>September 8, 2016</study_first_submitted>
  <study_first_submitted_qc>September 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 13, 2016</study_first_posted>
  <last_update_submitted>August 8, 2019</last_update_submitted>
  <last_update_submitted_qc>August 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

